{"SPADE_UN_17762": {"Clinical Information": [], "Patent Information": [{"Patent No": "CN110662759A", "Patent Link": "http://www.lens.org/lens/patent/CN110662759A", "Patent Type": "Granted Patent", "Publication Date": "2020-1-7", "Family Info": "Notavailable", "Patent Title": "Tumour-Targeting Peptide Variants", "Abstract": "The present invention provides peptides that selectively bind to α v β 6 integrin, said peptides having a motif comprising X1BnRGDLX2X3X4ZmX5Wherein X is1Is any D-amino acid, BnIs any sequence of n amino acids, which may be natural or non-natural, D-or L-and may be identical or different, where n is a number from 1 to 10, X2And X3Independently selected from any amino acid, X4Is Leu or Ile, ZmIs a sequence of any m amino acids, which may be natural or non-natural, D-or L-and may be identical or different, where m is a number from 1 to 10, X5Is any L-or D-amino acid. Also provided are conjugates comprising the peptides,pharmaceutical compositions comprising said peptides or said conjugates and uses of said peptides, conjugates or compositions for the treatment, imaging and/or diagnosis of α v β 6 expressing tumors in a mammalian subject, for example."}], "Sequence Information": {"SPADE ID": "SPADE_UN_17762", "Sequence": "NKVPNLRGDLQVLAQKVART", "Sequence Length": 20, "Peptide Name": "SEQ ID: 8 of Patent CN110662759A", "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Frequent Amino Acids": "LVA", "Absent Amino Acids": "CEFHIMOSUWY", "Basic Residues": 4, "Acidic Residues": 1, "Hydrophobic Residues": 9, "Polar Residues": 14, "Positive Residues": 4, "Negative Residues": 1, "Mass": 2220.57, "PI": 11.0, "Net Charge": 3, "Hydrophobicity": -0.47, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17764", "Similarity": 1.0, "Sequence": "NKVPNLRGDLQVLAQKVAR"}, {"SPADE_ID": "SPADE_UN_17647", "Similarity": 0.95, "Sequence": "NAVPNLRGDLQVLAQKVART"}, {"SPADE_ID": "SPADE_UN_17761", "Similarity": 0.95, "Sequence": "NAVPNLRGDLQVLAQKVART"}]}}}